30 Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Cancer Genetics, Inc. CGIX rose 88.2% to $0.32 in pre-market trading after reporting Interpace Diagnostics will purchase the company's Biopharma services unit.
• Universal Security Instruments, Inc. UUU rose 16.7% to $1.40in pre-market trading after reporting fourth-quarter earnings and sales were higher from last year.
• Cinedigm Corp CIDM shares rose 15.7% to $1.40 in pre-market trading after the company's 8-K showed a common stock purchase agreement with Bison Entertainment and Media Group for 2 million shares at $1.50 per share.
• Bio-Path Holdings, Inc. BPTH rose 14% to $14.70 in pre-market trading. H.C. Wainwright initiated coverage on Bio-Path with a Buy rating and a $28 price target.
• Interpace Diagnostics Group, Inc. IDXG rose 10% to $0.7680 in pre-market trading. Interpace Diagnostics reported the purchase of Biopharma Services unit of Cancer Genetics. Ampersand Capital Partners agreed to invest $27 million in Interpace Diagnostics in two tranches of newly issued convertible preferred stock.
• Xenetic Biosciences, Inc. XBIO rose 9.3% to $11.68 in pre-market trading after falling 13.28% on Monday.
• AngioDynamics, Inc. ANGO rose 8.9% to $23.70 in pre-market trading.
• Perion Network Ltd. PERI shares rose 7.3% to $4.29 in pre-market trading after surging 13.64% on Monday.
• J.B. Hunt Transport Services, Inc. JBHT rose 7.1% to $99.13 in pre-market trading after reporting second-quarter earnings.
• Amneal Pharmaceuticals, Inc. AMRX rose 5.1% to $3.69 in pre-market trading after declining 5.14% on Monday.
• Tata Motors Limited TTM shares rose 4.6% to $12.20 in pre-market trading.
• JinkoSolar Holding Co., Ltd. JKS shares rose 3% to $20.90 in pre-market trading.
• Biohaven Pharmaceutical Holding Company Ltd. BHVN rose 3% to $47.05 in pre-market trading after rising 7.53% on Monday.
• Arcus Biosciences, Inc. RCUS rose 2.9% to $8.57 in pre-market trading.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Camber Energy, Inc. CEI fell 7.6% to $3.52 in pre-market trading.
• Celestica Inc. CLS fell 7.3% to $6.20 in pre-market trading..
• Wintrust Financial Corporation WTFC shares fell 7.2% to $65.00 in pre-market trading after reporting Q2 results.
• Capricor Therapeutics, Inc. CAPR fell 6.7% to $5.81 in pre-market trading after climbing 93.48% on Monday.
• pdvWireless Inc ATEX fell 6% to $44.00 in pre-market trading after reporting an $85 million common stock offering.
• Domino's Pizza, Inc. DPZ fell 5.5% to $255.06 in pre-market trading after the company reported worse-than-expected Q2 sales.
• Qutoutiao Inc. QTT fell 5.3% to $4.30 in pre-market trading. Qutoutiao disclosed that its Midu Novels will undergo product upgrades and temporarily suspend content updates and certain commercial activities.
• Arrow Electronics, Inc. ARW fell 5% to $65.48 in pre-market trading after the company cut its Q2 EPS and sales guidance below analyst estimates.
• FactSet Research Systems Inc. FDS fell 4.9% to $280.00 in pre-market trading. Morgan Stanley downgraded FactSet Research from Equal-Weight to Underweight and lowered the price target from $264 to $263.
• Flex Ltd. FLEX fell 4.5% to $9.31 in pre-market trading.
• Cognex Corporation CGNX fell 4.4% to $40.65 in pre-market trading. Goldman Sachs downgraded Cognex from Neutral to Sell and lowered the price target from $45 to $36.
• HUYA Inc. HUYA fell 4.3% to $23.25 in pre-market trading.
• Medical Properties Trust, Inc. MPW fell 4.2% to $17.52 in pre-market trading. Medical Properties Trust priced its 45 million share public offering of common stock at $17.29 per share.
• Fiat Chrysler Automobiles N.V. FCAU fell 4.2% to $13.59 in pre-market trading. Goldman Sachs initiated coverage on Fiat Chrysler with a Sell rating.
• Change Healthcare Inc. CHNG fell 4.1% to $14.20 in pre-market trading.
• Kennametal Inc. KMT fell 3.8% to $33.45 in pre-market trading. Goldman Sachs downgraded Kennametal from Buy to Sell and lowered the price target from $43 to $30.